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Abstract
Hospital acquired pneumonia (HAP) is often fatal in older patients. The mouth is the main
reservoir of infection and studies have suggested that oral hygiene interventions may pre-
vent HAP. The aim of this study was to investigate associations between HAP and preced-
ing a) heavy dental plaque and b) oral carriage of potential respiratory pathogens in older
patients with lower limb fracture to determine the target for intervention studies.
Methods
We obtained a time series of tongue/throat swabs from 90 patients with lower limb fracture,
aged 65-101 in a general hospital in the North East of England between April 2009-July
2010. We used novel real-time multiplex PCR assays to detect S. aureus, MRSA, E. coli,
P. aeruginosa, S. pneumoniae, H. influenza and Acinetobacter spp. We collected data on
dental/denture plaque (modified Quigley-Hein index) and outcomes of clinician-diagnosed
HAP.
Results
The crude incidence of HAP was 10% (n = 90), with mortality of 80% at 90 days post dis-
charge. 50% of cases occurred within the first 25 days. HAP was not associated with being
dentate, tooth number, or heavy dental/denture plaque. HAP was associated with prior oral
carriage with E. coli/S. aureus/P.aeruginosa/MRSA (p = 0.002, OR 9.48 95% CI 2.28-
38.78). The incidence of HAP in those with carriage was 35% (4% without), with relative risk
6.44 (95% CI 2.04-20.34, p = 0.002). HAP was associated with increased length of stay
(Fishers exact test, p=0.01), with mean 30 excess days (range -11.5-115). Target organ-
isms were first detected within 72 hours of admission in 90% participants, but HAP was sig-
nificantly associated with S. aureus/MRSA/P. aeruginosa/E. coli being detected at days 5
(OR 4.39, 95%CI1.73-11.16) or 14 (OR 6.69, 95%CI 2.40-18.60).
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Conclusions
Patients with lower limb fracture who were colonised orally with E. coli/ S. aureus/MRSA/P.
aeruginosa after 5 days in hospital were at significantly greater risk of HAP (p = 0.002).
Introduction
Hospital acquired pneumonia (HAP) is now the most common hospital associated infection in
England[1] and one of the most common complications following lower limb fracture in older
adults, (incidence of 8.6–10%, [2–4] mortality of 12–43% [2, 5–7]). Efforts to prevent HAP are
important because of the associated high mortality, hospital costs, functional decline and in-
creased length of stay [8–10]. HAP appears to arise from interactions between three main risk
factor groups: resident oral microbiota, aspiration potential (dysphagia, reduced conscious
level) and host factors (age, frailty, comorbidity); the first is the most easily modifiable, despite
not having the strongest effects. However few studies include non-ventilated, frail older pa-
tients because of difficulties with diagnosis and recruitment, despite these patients making up
the majority of HAP cases.
The mouth is the main reservoir of infection, and matching organisms (>95% similarity by
pulse-field gel electrophoresis) have been detected in dental plaque and bronchoalveolar lavage
fluids in patients with ventilator associated pneumonia (VAP) [11], implicating aspiration of
organisms within dental plaque as the cause of the pneumonia. In addition, aspiration pneu-
monia was reported to be associated with increased number of teeth or decayed teeth, presence
of Staphylococcus aureus in saliva and Porphyromonas gingivalis in dental plaque in dentate pa-
tients [12]. It is therefore possible that dental plaque, a removable matrix rich with oral bacteria
which is a pre-requisite for caries, is the common driver. Dental plaque has been implicated as
a reservoir for potential respiratory pathogens not usually native to the mouth[11, 13–16], such
as Enterobactericeae. Interventions to reduce the oral bioburden and thus pneumonia have
been successfully trialled in ventilated patients [17–19], and combined with professional dental
hygienist intervention, with moderate success in nursing home residents [20, 21]. An interven-
tion trial of tooth-brushing up to four times daily resulted in a 37% reduction in cases of HAP,
with cost savings of $1.6 million in avoided antibiotics and bed days [22].
However, oral hygiene interventions also successfully decreased febrile days in edentate (no
teeth) patients in nursing homes in Japan [20], and similar rates of pneumonia have been ob-
served regardless of whether dentate or edentate [20, 23]. In addition, S. aureus and coliform
bacteria were most often found in saliva and soft tissue [24], and colonisation with respiratory
pathogens correlated poorly with heavier dental plaque in other studies [14, 16]. Given that the
majority of culture-positive HAP has been aetiologically linked with non-dental organisms
such as Escherichia coli, S. aureus etc.[25], the relative contributions of these organisms versus
dental plaque associated organisms is unclear. In addition, some oral hygiene intervention
studies in ventilated patients have produced negative results [26, 27].
While numerous studies linking VAP with oropharyngeal colonisation with respiratory
studies have been conducted, few studies have linked non-ventilated HAP with prior oropha-
ryngeal colonisation [28–31]. Of these, one was a case-control study[28], one was of lung can-
cer patients undergoing operative treatment [30], another of upper abdominal surgical patients
[31], and the fourth was a ten year follow up study of limited baseline data, which did consider
dentition [29]. All of these studies used culture to determine colonisation, and took samples at
one-two time points.
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In order to design a robust oral hygiene intervention it was important to clarify the relative
importance of oropharyngeal colonisation (and which organisms therein were important),
dentition and dental/denture plaque to the development of HAP in older patients, and under-
stand how these potential risk factors interacted. In addition no studies had used molecular
methods to detect bacteria, nor taken time series of samples to determine the effects of hospita-
lisation on the oral flora.
The aim of this study was to investigate whether HAP was associated with a) prior oral car-
riage of respiratory pathogens or b) prior heavy dental or denture plaque. We included old,
frail and cognitively impaired patients as these are the characteristics of the majority of patients
in hospital. We chose patients with hip or other lower limb fracture because, for most, opera-
tive intervention is mandatory, and reducing post-operative pneumonia in this group is there-
fore unarguable despite frailty, advanced age or impaired cognition. Given that bronchoscopy
would have been inappropriate in many patients, we used clinician diagnosis of HAP, sup-
ported by American Thoracic Society guidelines.
The main aim of the study was to determine whether HAP was commoner in patients
whose mouths had acquired or become colonised by organisms detectable by the PCR panel
within 14 days of hospital admission.
Materials and Methods
Patients with lower limb fracture were recruited prospectively from the orthopaedic wards at
Newcastle General Hospital. We took oral samples (tongue and throat) at five time-points dur-
ing the admission (1, 3, 5, 7 and 14 days after admission). We also undertook three dental ex-
aminations to assess tooth number and dental/denture plaque 1, 7 and 14 days after admission.
Frailty indices were calculated and demographic data were recorded at the first visit. Patients
were followed up thrice weekly until discharge to ascertain cases of pneumonia, and case notes
were reviewed weekly. Follow-up telephone calls to patient and General practitioner were
made at 90 days. During study recruitment, we developed novel real-time PCR assays to char-
acterise the oral colonisation dynamics of seven major respiratory bacterial pathogens. Anon-
ymised oral samples were then analysed using the real-time multiplex PCR assays after
recruitment had terminated. We then prospectively investigated associations between inci-
dence of a) infection events (HAP), and b) colonisation events by real-time PCR, dental, micro-
biological and medical risk factors. We used Fisher’s exact test and univariate generalised
linear models for the former and multivariate generalised linear models for the latter. Further
details are given below.
Patient recruitment and consent
Patients were identified at the daily trauma meeting at Newcastle General Hospital between
April 2009-July 2010. Recruitment occurred pre-operatively where possible, or on the first
post-operative day otherwise.
Inclusion criteria were age>65 and lower limb fracture. Exclusion criteria were immuno-
suppression within last three months (immunosuppressive drugs, chemotherapy or radiothera-
py or> = 10mg oral prednisolone but not inhaled steroids), acute illness, palliative care and
community acquired pneumonia. We excluded patients with acute illness because operative
treatment was delayed in this group due to urgent medical therapy being given. Assuming that
perioperative antibiotics, anaesthetic with laryngeal mask airway, and operation might affect
the oral flora, it would be difficult to compare acutely unwell patients with those who were op-
erated upon within 48 hours of admission. Immunosuppression was an exclusion criterion be-
cause the immune system is likely to play an important role in determining membership and
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diversity of the oral microbiota, and ought to studied separately. The sample was therefore bi-
ased towards “well” patients.
A power calculation, based on a presumed exposure (oral colonisation) of 20% and outcome
incidence of HAP of 10% in unexposed at 80% power and the 0.05 significance level suggested
that recruiting 200 patients would be able to detect a 20% difference in the incidence of HAP
between colonised and uncolonised persons [32]. An exposure of 20% was based on two previ-
ous papers [33, 34], and the incidence of HAP was based on 9% incidence found by Roche
et al. [2].
Ethics statement
Ethical approval was granted by the Newcastle and North Tyneside 2 research ethics commit-
tee, which had a special interest in adults lacking capacity. The research was conducted as per
the Mental Capacity Act 2005 (United Kingdom) guidelines, and every effort was made to in-
clude all persons with cognitive impairment because these are the very people that hospital ac-
quired pneumonia affect. To exclude these persons would mean that the research outcomes
would be less useful when applying results to real life populations. In addition, the taking of
oral swabs was deemed minimally intrusive and wholly without risk to participants.
Written patient consent was obtained. Where there were concerns regarding capacity, a ca-
pacity assessment was undertaken by VE (Could the patient take in, believe, weigh the informa-
tion and come to a reasoned judgement?). All efforts were made to allow patients to make their
own decision, including repeating information, visits at different times and finding visual or
hearing aids. If the patient was found not to have capacity, then a relative (personal consultee)
was sought and invited to provide written consent on the patient’s behalf, taking into account
what they knew of their relative’s beliefs, wishes and condition. If the patient had no relatives
then a professional independent of the study was sought (professional consultee), and invited
to provide written consent, again taking into account the patient’s condition. According to the
Act, a researcher may nominate another individual who is not connected to the project accord-
ing to local guidelines to act on the participant's behalf. In this study, one patient fell into this
category, and a qualified nurse who had been caring for that patient acted on their behalf. No
power of attorney was assigned. The nurse was unconnected with the study and its personnel,
and had not previously worked together. If any patient showed any signs of not wishing to take
part in the study (for example, closing mouth to swabs or appearing unhappy or distressed)
they were immediately withdrawn, even if written consent had been provided on their behalf.
Routine Care
All patients (apart from two treated without operation) received peri-operative antibiotics
(three doses of cefuroxime 750mg 12 hourly until August 2009, three doses of teicoplanin
400mg 12 hourly thereafter). All patients received 4500 international units of tinzaparin subcu-
taneously, unless already anticoagulated on warfarin. Routine postoperative analgesia was co-
codamol 30/500mg four times daily. Patients were routinely screened for MRSA and decolo-
nised with chlorhexidine mouthwash and antibacterial toothpaste if found positive. No specific
oral hygiene policy was in operation at the time of the study and the study team did not under-
take any oral hygiene intervention. Patients relied on nursing staff helping with oral hygiene
and bringing equipment to their beds if unable to mobilise, and leaving equipment within their
reach. Patients with dentures were given denture pots if these were available, but these did not
necessarily contain fluid.
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Recording of demographic variables
We recorded demographic data including age, residence, gender, weight, comorbidity, and
prescribed drugs. We calculated functional scores, including the Barthel index (0–20, with
20 meaning needs no help with activities of daily living) [35], the Clinical Frailty scale (1–9,
1 being the fittest, increasing with frailty) [36] and the Hierarchical Assessment of Balance and
Mobility (HABAM) score (1–63, higher score meaning better mobility)[37]. We also calculated
Charlson comorbidity indices (www.medal.org) for each participant. All data were entered into
a Microsoft Access database (VE). Complications were recorded prospectively from case notes
review. Aspiration episodes were noted opportunistically (i.e. choking episode witnessed by re-
search team while giving patient a drink during sample collection) rather than systematically,
and are included for interest.
Recording of oral hygiene variables
The number of teeth or teeth on dentures was recorded. Dental and denture plaque (full
mouth) were scored by the bedside at days 1, 7 and 14 using the modified Quigley Hein index
(VE) [38, 39]. Scores of 0–5 were recorded for each tooth surface (2 per tooth) with 0 meaning
no visible plaque and 5 meaning over 2/3 of tooth covered in plaque. Midway through the
study, intra-rater calibration using 138 surfaces gave kappa scores of 80.9% (good). Dentures
in use were removed for scoring, and were not cleaned. Dentures not in use were not scored. In
order to create a single plaque score per patient, a quartile score was assigned to modified Quig-
ley Hein indices (both dental and denture), and where scores were discordant, the higher score
was used (disclosing tablets could not be used and therefore scores may have been under-
estimated).
Collection of oral samples
Flocked swabs were used to sample the tongue and throat at days 1, 3, 5, 7, and 14 (or nearest
working day) between 8.30am-12 pm, or 1-4pm. No special instructions were given to patients
prior to sample collection.
Throat swabs were taken from anterior faucial pillars, using a back-and-forth motion three
times. Tongue swabs were taken by making three strokes posteriorly-anteriorly, then rotating
the swab 180° and making a further three strokes. Swab tips were transferred into 2ml micro-
tubes, transported to the Health Protection Agency (HPA) within four hours of collection, and
stored at 2–8°C until DNA extraction within 48 hours. Samples were anonymised and stored at
-80°C after DNA extraction.
Diagnosis of HAP and HAP/LRTI
HAP was recorded when antibiotics were started for pneumonia by the responsible clinician
after 48 hours in hospital (that is, a clinical endpoint). The diagnosis was further characterised
using American Thoracic Society (ATS) [40] and British Society for Antimicrobial Chemother-
apy (BSAC) guidelines [41], both of which required a chest radiograph with new infiltrates.
ATS guidelines also require two of fever>38°C, leucocytosis or leucopoenia and purulent se-
cretions. BSAC guidance suggests purulent tracheal secretions and new/persistent infiltrates on
chest radiograph, increased oxygen requirement, leucocytosis>10,000 /mm3 or<4,000/mm3,
and core temperature >38.3°C can be used to identify those who would benefit from antibiot-
ics. It should be noted that these criteria were validated on ventilated patients. Episodes of
lower respiratory tract infection (LRTI) were also noted, and were diagnosed by clinician initi-
ated antibiotics for productive cough in the absence of positive chest x-ray findings. If a patient
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was commenced on intravenous antibiotics for productive cough but died of this illness with-
out a chest x ray, this was considered to be pneumonia.
Real-time PCR analysis
Anonymised samples were analysed using multiplex real-time PCR assays after patient follow-
up was complete (September 2010-December 2011) by a single clinical scientist (GE). The as-
says detected S. aureus, Meticillin resistant S. aureus (MRSA), E. coli, Pseudomonas. aeruginosa,
Streptococcus pneumoniae,Haemophilus influenzae, Acinetobacter spp. and the gap gene
(human housekeeping gene). The five-well multiplex real-time PCR assays were designed in
conjunction with the Health Protection Agency Newcastle for this study (unpublished, S. aure-
us and MRSA and gap assays taken from existing literature [42, 43]), and the primers and
probe sequences used in these assays are shown in S1 Table.
Real time PCR assays were carried out in 50μl volumes and contained 25μl Universal PCR
master mix (Applied Biosystems, Warrington, UK), primers (final concentration 20μM), probe
(final concentration 10μM), 5μl of DNA template and PCR grade water. Thermal cycling and
data analysis were conducted on two Taqman 7500 instruments (Applied Biosystems). Ther-
mal cycling conditions were as follows: 50°C for 2 minutes, 95°C for 10 minutes, then 40 cycles
of 95°C for 15s then 60°C for 1 min.
The assays were successfully validated on 63 previously identified clinical culture isolates of
target and oral bacteria (sensitivity 100% confidence intervals 83–100%, specificity 88% CI 74–
95%).
Definitions of acquisition and colonisation
PCR results (CT values) were converted to a binary value. A CT value of 40 or more was con-
sidered negative, and CT<40 positive, for all assays apart from E. coli and Acinetobacter. E. coli
and Acinetobacter assays were considered negative if> or = 35, and positive if<35 because
there was evidence of PCR mastermix (E. coli) and DNA extraction buffer fluid (Acinetobacter)
reagent contamination from negative control samples. Despite changing to a “cleaner” batch of
mastermix, testing negative control samples with the E. coli assay still produced some CT val-
ues of>35, and for this reason a higher threshold was applied to accepting a positive result
from these assays. Nothing could be done to mitigate the effects of the contaminated buffer
fluid, but all CT values for negative controls tested with the Acinetobacter assay were>35, so
again this threshold was adopted.
Acquisition was defined as the presence of an organism in one or more samples. Coloniza-
tion was defined as two or more samples positive (non-consecutive or consecutive). A “coloni-
sation index” was calculated by dividing total number of positive samples by the number of
samples taken for each organism per patient.
Data analysis
Anonymised data were manually checked and cleaned in Microsoft Excel (versions 2007–
2010) prior to analysis. Analysis was undertaken in R (R: A language and environment for Sta-
tistical computing, Vienna, Austria). Missing data were labeled as “NA” and were excluded
from analysis in R. Fisher’s exact test and univariate generalized linear modelling (GLM) were
used to investigate the relationships between HAP and explanatory variables, and univariate
GLMs were used to investigate HAP or lower respiratory tract infections (LTTI) with explana-
tory variables. In order to investigate whether colonization with individual organisms was asso-
ciated with dental covariates, a multivariate generalised linear model with binomial error
structure (analogous to multiple logistic regression) was used to test a dental model. Factors
Dental/Microbiological Risk Factors for Hospital-Acquired Pneumonia
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included in the model were age, clinical frailty score, Barthel index, Charlson comorbidity
index, deprivation index, place of residence, number of teeth, presence of dentures, gender,
presence of active cancer, smoking status and plaque score at admission. These factors were
included as putative drivers of colonization, based on previous observational studies [16, 28,
44–47]. To our knowledge, deprivation has not been studied as a risk factor for colonization
with potential respiratory pathogens but seemed a sensible additional risk factor given that it
drives many of the other factors e.g. smoking, tooth number. Patients who died were included
in the analysis.
Results
341 patients were screened, with a final cohort of 90 patients who were followed up for HAP
(Fig 1) and 93 patients from whom oral sampling data were available. Recruitment was difficult
due to timing, and there were periods where there were few potential participants. This led to
under-recruiting to the study, and the recruitment period could not be extended. Reasons for
non-participation of eligible patients included logistic (n = 52 e.g. no personal consultee), mori-
bund/aggressive (n = 35), in pain/too tired (n = 20), or no reason given (n = 83). Patients ad-
mitted on Friday/Saturday were frequently not recruited, which may have led to a more “well”
cohort given the increased risks of weekend hospital admission [48]. 14/90 (16%) needed a per-
sonal or professional consultee. One patient was lost to follow-up, but his GP confirmed he
had received no antibiotics post-discharge and he was therefore treated as not having devel-
oped HAP/LRTI. Three patients were found to be positive for MRSA and were treated with
chlorhexidine mouth rinse and medicated toothpaste as part of the hospital’s decontamination
protocol. None of these patients developed HAP.
816 samples were collected from 93 patients (408 = tongue swabs, 408 = throat swabs). Sam-
ples were taken at four or five time-points from 83 participants, at two or three time-points in
eight participants, and once in two participants (first sample preoperatively n = 50, post-opera-
tively n = 43). Eleven patients missed one sample for logistic reasons.
The majority of patients (86/93) had sustained fractures to the neck of femur; others had
fractured the femoral shaft (n = 2) or ankle (n = 5). Two patients did not undergo operation
(stable ankle fractures). Three patients withdrew after sampling but before follow up, all of
whom had sustained fractures to their neck of femur, leaving a final cohort of 90. Three pa-
tients had been decolonised for MRSA. Baseline characteristics of the study cohort are shown
in Table 1. Fifty patients possessed teeth (median 16.5, range 1–50), of which 24 also wore den-
tures, a further 42 only wore dentures (no teeth) and one person had neither teeth nor wore
dentures. Of dentate patients, the dental plaque indices at admission ranged from 0.2–3.5 with
median score 1.2. Of those who wore dentures, scores ranged from 0–1.5, with a median score
of 0.55 in dentate and 0.7 in edentulous persons (p =<0.001). Dental plaque but not denture
plaque scores increased generally over the three examinations, but non-significantly. Com-
bined dental/denture plaque scores had a median value of 2 (range 1–4).
Microbiological sampling
Of 93 patients, 23 patients had negative swabs and a further 26 had transient acquisition of or-
ganisms. The other 44 had single (n = 22) or mixed pathogen carriage/acquisition (n = 22). Of
51 colonisation events (one patient could have>1), colonisation with S. pneumoniae was com-
monest (n = 27), followed byH. influenzae (n = 8), S. aureus (n = 6), P. aeruginosa (n = 4),
MRSA (n = 3) and E. coli/Acinetobacter spp (both n = 2). Certain combinations of pathogens
were seen more frequently. Disregarding the persistence of the organisms, the commonest
combinations of organisms were S. pneumoniae and H. influenzae (n = 11), S. aureus and
Dental/Microbiological Risk Factors for Hospital-Acquired Pneumonia
PLOS ONE | DOI:10.1371/journal.pone.0123622 April 29, 2015 7 / 23
MRSA (n = 10), E. coli andH. influenzae (n = 5), and S. pneumoniae and P. aeruginosa (n = 5).
Colonisation indices were highest in S. pneumoniae, indicating most persistent carriage.
Colonising organisms (i.e. detected twice or more) were first detectable within 72 hours of
admission in 90% of cases (Fig 2).
Fig 1. Consort diagram of screened study participants.
doi:10.1371/journal.pone.0123622.g001
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Table 1. Baseline characteristics of study cohort, shown by patients with or without HAP (Fisher’s exact test).
Variable All patients (n = 90)
Mean, Median (range)1
HAP (n = 10) Mean,
Median (range) 1
No HAP (n = 80) Mean,
Median (range) 1
P value Odds ratio(96%
confidence interval)
to 2 d.p.
>2 samples positive, any bug 53/90 8/10 45/80 0.188 3.08 (0.56–31.53)
>2 samples positive,
opportunistic orgs only1
17/90 6/10 11/80 0.003* 9.05 (1.82–51.27)
S. aureus col index 0.06,0 (0–1) 0.14, 0 (0–1) 0.05,0 (0–1) 0.091
MRSA col index 0.03, 0 (0–1) 0.05,0 (0–0.37) 0.03, 0 (0–1) 0.197
E. coli col index 0.03,0 (0–1) 0.14,0 (0–1) 0.02,0 (0–0.5) 0.036*
P. aeruginosa col ind 0.03,0 (0–0.5) 0.05,0 (0–0.4) 0.03,0 (0–0.5) 0.125
S. pneumoniae col ind 0.25,0 (0–1) 0.12.0 (0–0.87) 0.27,0 (0–1) 0.771
H. influenzae col ind 0.08,0 (0–0.9) 0.05,0 (0–0.25) 0.09,0 (0–0.9) 0.330
Acinetobacter sp col ind 0.01, 0 (0–0.33) 0,0 (0) 0.02,0 (0–0.33) 1
Age 81 83.5 80.58 0.061
Female 61/90 5/10 56/80 0.281 0.43 (0.09–2.07)
Clinical Frailty Scale 4.29 5 4.2 0.570
Charlson index 5 7.4 5.1 0.067
HABAM (mobility score) 52 45.7, 50.5 (18–61) 52.4 0.194
Barthel score 18.17, 20 (4–20) 16.1, 19 (4–20) 18.43, 20 (4–20) 0.143
Number of teeth 8.5, 5 (0–28) 10, 7 (0–27) 8.3, 3.5 (0–28) 0.353
Denture wearing 64/90 (71%) 8/10 56/80 0.718 1.71 (0.31–17.66)
Home dwelling 75/90 (83%) 6/10 69/80 0.058 0.24 (0.05–1.37)
PQS day 1 n = 89 2.4, 2 (1–4) 1.9, 3 (1–4) 2.5, 2 (1–4) 0.265
PQS day 7 n = 78 2.7, 3 (1–4) 3, 3.5 (1–4) 2.6, 3 (1–4) 0.403
PQS day 14 n = 61 2.5, 3 (1–4) 3, 3 (1–4) 2.4, 2 (1–4) 0.451
Deprivation score 26.2, 20.5 (2.3–71.7) 18.67, 14.0 (3.7–49.5) 27.1, 22.4 (2.3–71.7) 0.058
Number of drugs (admission) 6 5.9 6.3 0.758
Proton pump inhibitor 26/90 2/10 24/80 0.718 0.59 (0.06–3.25)
Angiotensin converting
enzyme inhibitor
20/90 1/10 19/80 0.448 0.36 (0.01–2.90)
Sedating drugsa 32/90 6/10 26/80 0.157 3.07 (0.66–16.15)
Inhaled steroid 14/90 0/10 14/80 0.351 0.00 (0.00–2.41)
Oral steroid (<7.5mg) 6/90 1/10 5/90 0.517 1.66 (0.03 17.49)
Statin 48/90 7/10 41/80 0.327 2.20 (0.46–14.12)
Cefuroxime perioperatively 20/87 3/10 17/77 0.690 0.66 (0.13–4.41)
Teicoplanin perioperatively 67/87 7/10 60/77 NA
Number of comorbidities
n = 89
6 6.4 6.4 0.913
Number of complications 10, 8 (0–50) 21.6, 18.5 (5–50) 8.4, 7 (0–36) 0.001*
COPD 17/90 (19%) 1/10 16/80 0.680 0.45 (0.01–3.67)
Any respiratory comorbidity 21/90 (23%) 3/10 18/80 0.693 1.47 (0.22–7.30)
Cerebrovascular disease 16/90 (18%) 1/10 15/80 0.684 0.48 (0.01–4.00)
Cardiovascular disease 30/90 (33%) 3/10 27/80 1 0.84 (0.13–4.06)
Diabetes mellitus 9/90 (10%) 2/10 7/80 0.261 2.57 (0.22–17.15)
Dementia 6/90 (7%) 2/10 4/80 0.131 4.62 (0.36–38.76)
Active cancer 4/90 (4%) 4/10 3/80 0.002* 15.97 (2.18–136.36)
Antibiotics pre admission 15/90 (17%) 3/10 12/80 0.361 2.40 (0.35–12.51)
Current smoking 14/90 (16%) 2/10 12/80 0.651 1.41 (0.13–8.40)
Current or ex smoking 60/90 (67%) 8/10 52/80 0.486 2.4 (0.39–22.0)
(Continued)
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Hospital Acquired Pneumonia
Ten of 90 patients were defined as having HAP (clinician initiated antibiotics), of whom seven
fulfilled ATS/BSAC criteria, one who was too ill for a chest radiograph and died (death certifi-
cate recorded 1a as being pneumonia) and two others who had new infiltrates on chest radio-
graph but had only one of the minor criteria. A further eight patients developed LRTI. Two
anonymised datasets are included (S1 Dataset: Anonymised patient data with PCR results (CT
values) and S2 Dataset: Anonymised patient results with PCR results expressed as colonisation
indices) comprising PCR results from these 90 patients, along with other covariates studied. A
third file (S3 Dataset) contains the codes of categorical data within the dataset.
Two patients grew S. pneumoniae from sputum and a third grewH. influenzae (all three car-
ried S. pneumoniae on oral study samples). Of the ten patients defined as having HAP, eight
(80%) died, six in hospital and two after discharge. Total number of days in hospital for the 90
patients was 3454, and each patient was also followed up for 90 days post discharge (8100
days), giving a total of 11,554 days studied, and thus risk of first episode of HAP per day was
0.0009. Around 50% of cases arose within the first 25 days in hospital, and 75% occured within
the first six weeks of admission (Fig 3). Having HAP was associated with a significantly in-
creased length of stay (Fisher’s exact test, p = 0.01), with a mean excess number of days in hos-
pital per person of 30 days (range -11.5–115).
HAP was not associated with being dentate, tooth number, having dentures or combined
denture/dental plaque score at any time point during admission (Tables 1 and 2). HAP was not
significantly associated with 2 or more positive samples (colonisation) of a combined group of
all organism tested. However it was noted that the estimates for S. pneumoniae andH. influen-
zae were negative, suggesting a trend towards a protective effect. Thus we combined those or-
ganisms with models which had positive estimates into one group (‘opportunistic organisms’),
which comprised S. aureus, MRSA, P. aeruginosa and E. coli. We did not include Acinetobacter
in this group because the model produced by relating HAP with Acinetobacter spp was so poor
(probably because only three patients were colonised with Acinetobacter spp—one with three
samples positive and the other two with two samples positive). When we removed S. pneumo-
niae,H. influenzae and Acinetobacter spp. from the group, HAP was significantly associated
Table 1. (Continued)
Variable All patients (n = 90)
Mean, Median (range)1
HAP (n = 10) Mean,
Median (range) 1
No HAP (n = 80) Mean,
Median (range) 1
P value Odds ratio(96%
confidence interval)
to 2 d.p.
Operation length (mins) n = 87 88.90 91.50 88.56 0.175
Witnessed aspiration episode 4/90 (4%) 3/10 1/80 0.004* 30.88 (2.18–1773.08)
Length of stay (days) 38, 26 (4–265) 54.9, 46 (13–140) 36.31, 24.50 (4–265) 0.010*
Death (all causes) 15/90 (17%) 8/10 7/80 <0.001* 38.18 (6.14–434.01)
Death (excluding active
cancer) n = 83
11/83 (12%) 4/10 7/73 0.001* 17.23 (2.44–203.26)
HAP = hospital acquired pneumonia, HABAM = Hierarchical Assessment of Balance and Mobility, PQS = Plaque quartile score, COPD = Combined
obstructive pulmonary disease, d.p. = decimal places
*statistically significant p<0.01
aincludes benzodiazepines, selective serotonin reuptake inhibitors, tricyclic antidepressants, opiates, gabapentin or anti-epileptic drugs.
1Where mean and median were similar, only the mean is shown. Where there was large disparity between these values, mean, median and range
are given.
doi:10.1371/journal.pone.0123622.t001
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with prior colonisation by the opportunistic organisms group by univariate GLM (p = 0.002,
odds ratio 9.41 95% confidence intervals 2.28–38.78). The adjusted r-squared value for this
model was 0.203, suggesting that the presence of these organisms in the oropharynx explained
20% of the cases of HAP. The crude incidence of HAP in unexposed patients was 3/73 (4.1%),
while in exposed patients crude incidence of HAP was 6/17 (35.3%), a difference of 31.2%. The
relative risk of developing HAP if colonised with these organisms was 6.44 (95% CI 2.04–20.34,
p = 0.002).
Fig 2. Diagrammatic representation of the time-point during admission that each organism was first detected (when an organismwas detected
twice or more, i.e. colonisation). Note that these data are not cumulative, because some organisms might have been detected on the first sample, not on
the second and then been detected again on the third sample. The shaded area of each circle represents the number of patients in whom colonisation with
that organism was detected at that time-point. The vast majority of these organisms were first acquired on sample 1 or 2 (i.e. during the initial 3 days in
hospital), and not later in the hospital stay.
doi:10.1371/journal.pone.0123622.g002
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When testing for associations between HAP or HAP/LRTI and single organisms, only E.
coli (HAP, p = 0.036) or S. aureus (HAP/LRTI, p = 0.028, OR 25.95, 95%CI 1.43–471.92) were
significantly associated (Tables 1 and 3), though HAP was not significantly associated with E.
coli when using a GLM (Table 2, p = 0.07).
We also tested whether HAP was associated with samples positive for any of these opportu-
nistic organisms at each time point. HAP was significantly associated with opportunistic or-
ganisms being detected on oral samples at day 5 or 14 (Table 4).
HAP was associated with higher Charlson index (Table 2, p = 0.005, OR 1.46, 95%CI 2.28–
38.78), being admitted from hospital/institution (0.048, OR 4.18, 95% CI 1.01–17.23), having
Fig 3. Risk of HAP by number of days in hospital. The risk of HAP declined with number of days in hospital, with the highest risk being in the first six weeks
(green dashed lines). Around 50% of cases occurred within the first 25 days (red dashed lines).
doi:10.1371/journal.pone.0123622.g003
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Table 2. Relating HAP and patient factors using univariate generalised linear modelling.
Variable Estimate Standard
error
Z
value
Null
deviance
Residual
deviance
P
value
Odds ratio (95% confidence
intervals)to 2 d.p.
>2 samples positive, any bug 1.135 0.822 1.381 62.790 on
89
60.541 on 88 0.167 3.11 (0.62–15.58)
>2 samples positive,
opportunistic orgs only1
2.242 0.723 3.103 62.790 on
89
53.084 on 88 0.002
**
9.41 (2.28–38.78)
S. aureus col index 2.136 1.447 1.476 62.79 on
89
60.90 on 88 0.14 8.46 (0.50–144.33)
MRSA col index 1.146 1.980 0.579 62.790 on
89
62.502 on 88 0.563 3.14 (0.06–152.53)
E. coli col index 4.456 2.459 1.812 62.790 on
89
58.046 on 88 0.07. 86.17 (0.70–10680.08)
P. aeruginosa col ind 2.496 3.231 0.773 62.790 on
89
62.267 on 88 0.44 12.14 (0.02–6827.16)
S. pneumoniae col ind -1.390 1.224 -1.136 62.790 on
89
61.141 on 88 0.256 0.25 (0.02–2.74)
H. influenzae col ind -1.449 2.471 -0.586 62.790 on
89
62.367 on 88 0.558 0.23 (0.00–29.79)
Acinetobacter sp col ind -153.807 15919.098 -0.01 62.79 on
89
60.81 on 88 0.992 NA
Age 0.058 0.049 1.175 62.790 on
89
61.322 on 88 0.240 1.06 (0.96–1.17)
Clinical frailty scale 0.334 0.221 1.510 62.790 on
89
60.432 on 88 0.131 1.40 (0.91–2.15)
Decreased mobility -0.048 0.027 -1.767 62.790 on
89
59.817 on 88 0.077 0.95 (0.90–1.01)
Barthel index -0.121 0.069 -1.76 62.790 on
89
60.054 on 88 0.078. 0.89 (0.77–1.01)
Charlson index 0.382 0.137 2.788 62.790 on
89
54.803 on 88 0.005
**
1.46 (1.12–1.92)
Number of teeth 0.017 0.033 0.516 62.790 on
89
62.528 on 88 0.606 1.02 (0.95–1.09)
Day 1 PQS -0.492 0.323 -1.522 62.553 on
88
59.995 on 87 0.128 0.61 (0.32–1.15)
Day 7 PQS (n = 78) 0.3261 0.358 0.912 51.586 on
77
50.704 on 76 0.362 1.39 (0.69–2.79)
IMD -0.026 0.021 -1.258 62.553 on
88
60.718 on 87 0.208 0.97 (0.94–1.01)
Female -0.847 0.678 -1.250 62.790 on
89
61.255 on 88 0.211 0.43 (0.11–1.62)
HABAM (mobility) -0.048 0.027 -1.767 62.790 on
89
59.817 on 88 0.077. 0.95 (0.90–1.01)
Denture wearing 0.539 0.827 0.651 62.790 on
89
62.328 on 88 0.515 1.71 (0.34–8.68)
Not home dwelling 1.431 0.723 1.980 62.790 on
89
59.213 on 88 0.048 * 4.18 (1.01–17.23)
Number of drugs -0.027 0.085 -0.318 62.790 on
89
62.686 on 88 0.750 0.97 (0.82–1.15)
PPI -0.539 -0.539 -0.651 62.790 on
89
62.328 on 88 0.515 0.58 (1.68–0.20)
ACE-I -1.031 1.086 -0.949 62.790 on
89
61.653 on 88 0.343 0.36 (0.04–3.00)
Sedating drug 1.136 0.688 1.651 62.790 on
89
59.996 on 88 0.099. 3.12 (0.81–12.00)
(Continued)
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active cancer (p = 0.001, OR 17.11, 95% CI 3.09–94.80), or having a witnessed aspiration epi-
sode (p = 0.004, OR 33.86, 95% CI 3.10–370.07). It should be remembered that aspiration epi-
sodes were not collected systematically from all patients and this result may therefore be
biased. Having metastatic cancer adds six points to the Charlson index, while other comorbidi-
ties (other than HIV) only add one to two points, which may explain the collinearity seen be-
tween active cancer and increased Charlson index.
HAP/LRTI was also associated with increased Charlson index (p = 0.001, OR 1.48, 95%CI
1.17–1.86), having active cancer (p = 0.003, OR 13.46, 95%CI 2.35–76.95), witnessed aspiration
episodes (p = 0.026, OR 14.20, 95% CI 1.38–146.06), and>2 samples positive for opportunistic
organisms (p = 0.004, OR 5.60, 95% CI 1.75–17.92) (Table 3). Additionally, HAP/LRTI was as-
sociated with increased clinical frailty score (p = 0.007, OR 1.69, 95% CI 1.15–2.49), having
Table 2. (Continued)
Variable Estimate Standard
error
Z
value
Null
deviance
Residual
deviance
P
value
Odds ratio (95% confidence
intervals)to 2 d.p.
Inhaled steroids -16.679 1743.249 -0.010 62.790 on
89
59.185 on 88 0.992 NA
Oral steroids <7.5mg 0.511 1.151 0.444 62.790 on
89
62.611 on 88 0.657 1.67 (0.17–15.90)
Statin 0.797 0.725 1.099 62.790 on
89
61.494 on 88 0.272 2.22 (0.54–9.20)
Number of comorbidities -0.004 0.113 -0.037 62.790 on
89
62.788 on 88 0.97 1.00 (0.80–1.24)
COPD -0.811 1.091 -0.744 62.790 on
89
62.126 on 88 0.457 0.44 (0.05–3.77)
Any resp 0.390 0.740 0.526 62.790 on
89
62.524 on 88 0.599 1.48 (0.35–6.30)
Cerebrovascular disease -0.731 1.092 -0.669 62.790 on
89
62.263 on 88 0.503 0.48 (0.06–4.10)
Diabetes mellitus 0.958 0.884 1.084 62.790 on
89
61.757 on 88 0.278 2.61 (0.46–14.75)
Dementia 1.558 0.942 1.653 62.790 on
89
60.473 on 88 0.098. 4.75 (0.75–30.12)
Cardiovascular disease -0.173 0.729 -0.237 62.790 on
89
62.733 on 88 0.813 0.84 (0.20–3.51)
Active cancer 2.840 0.874 3.251 62.790 on
89
52.641 on 88 0.001
**
17.11 (3.09–94.80)
Antibiotics pre admit 0.887 0.758 1.171 62.790 on
89
61.539 on 88 0.242 2.43 (0.55–10.73)
Current smoking -0.348 0.850 -0.410 62.790 on
89
62.631 on 88 0.682 0.71 (0.13–3.74)
Ex or current smoker -0.767 0.825 0.8246 62.790 on
89
61.817 on 88 0.352 0.46 (0.09–2.34)
Length of stay (days)(log) 0.825 0.413 1.999 62.790 on
89
58.503 on 88 0.046 * 2.28 (1.02–5.12)
Witnessed aspiration 3.522 1.220 2.887 62.790 on
89
53.031 on 88 0.004
**
33.86 (3.10–370.07)
Abbreviations: HAP = hospital acquired pneumonia, d.p. = decimal places, PQS = plaque quartile score, IMD = Index of multiple deprivation score,
HABAM = Hierarchical Assessment of Balance and Mobility, PPI = proton pump inhibitor, ACE-I = Angiotensin converting enzyme inhibitor, Cef vs
teic = Whether the patient received Cefuroxime or Teicoplanin perioperatively, COPD = Combined obstructive pulmonary disease, Any resp = Any
respiratory comorbidity, log = logarithim
doi:10.1371/journal.pone.0123622.t002
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Table 3. Relating HAP/LRTI and patient factors using univariate generalised linear modelling.
Variable Estimate Standard
error
Z
value
Null
deviance
Residual
deviance
P value Odds ratio (95% confidence
intervals)to 2 d.p.
>2 samples positive, any bug 0.732 0.577 1.269 90.072 on
89
88.358 on 88 0.205 2.08 (0.67–6.45)
>2 samples positive,
opportunistic orgs only1
1.723 0.593 2.904 90.072 on
89
81.829 on 88 0.004
**
5.60 (1.75–17.92)
S. aureus col index 3.256 1.480 2.201 90.072 on
89
84.580 on 88 0.028 * 25.95 (1.43–471.92)
MRSA col index 3.484 2.086 1.670 90.072 on
89
86.456 on 88 0.095. 32.59 (0.54–1944.49)
E. coli col index 2.802 2.008 1.395 90.072 on
89
87.789 on 88 0.163 16.48 (0.32–843.60)
P. aeruginosa col ind 0.301 3.126 0.096 90.072 on
89
90.063 on 88 0.923 1.35 (0.00–619.09)
S. pneumoniae col ind -1.303 0.894 -1.457 90.072 on
89
87.503 on 88 0.145 0.27 (0.05–1.57)
H. influenzae col ind 0.619 1.345 0.460 90.072 on
89
89.870 on 88 0.645 1.86 (0.13–25.94)
Acinetobacter sp col ind -6.336 8.645 -0.733 90.072 on
89
89.295 on 88 0.464 NA
Age 0.062 0.039 1.577 90.072 on
89
87.378 on 88 0.115 1.06 (0.99–1.15)
Clinical frailty scale 0.527 0.196 2.682 90.072 on
89
81.648 on 88 0.007
**
1.69 (1.15–2.49)
Barthel index -0.078 0.062 -1.253 90.072 on
89
88.605 on 88 0.210 0.93 (0.82–1.04)
Charlson index 0.389 0.119 3.267 90.072 on
89
78.302 on 88 0.001
**
1.48 (1.17–1.86)
Number of teeth 0.017 0.026 0.650 90.072 on
89
89.656 on 88 0.516 1.02 (0.97–1.07)
Day 1 PQS 0.327 0.236 1.385 89.623 on
88
87.645 on 87 0.166 1.39 (0.87–2.20)
Day 7 PQS 0.367 0.268 1.368 79.159 on
77
77.171 on 76 0.171 1.44 (0.85–2.44)
IMD -0.004 0.014 -0.322 89.623 on
88
89.518 on 87 0.748 1.00 (0.97–1.02)
Female -0.956 0.540 -1.770 90.072 on
89
86.971 on 88 0.077. 0.38 (0.13–1.11)
HABAM (mobility) -0.047 0.023 -2.064 90.072 on
89
85.788 on 88 0.039 * 0.95 (0.91–1.00)
Denture wearing 0.432 0.622 0.694 90.072 on
89
89.566 on 86 0.488 1.54 (0.46–5.21
Home dwelling 0.869 0.627 1.386 90.072 on
89
88.265 on 88 0.166 2.38 (0.70–8.15)
Number of drugs 0.062 0.062 1.007 90.072 on
89
89.075 on 88 0.314 1.064 (0.94–1.20)
PPI -0.068 0.587 -0.116 90.072 on
89
90.059 on 88 0.907 0.93 (0.30–2.95)
ACE-I -0.435 0.691 -0.63 90.072 on
89
89.650 on 88 0.529 0.65 (0.17–2.51)
Sedating drug 1.044 0.539 1.937 90.072 on
89
86.288 on 88 0.053. 2.84 (0.99–8.17)
Inhaled steroids -0.470 0.814 -0.577 90.072 on
89
89.711 on 88 0.564 0.63 (0.13–3.08)
(Continued)
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Table 3. (Continued)
Variable Estimate Standard
error
Z
value
Null
deviance
Residual
deviance
P value Odds ratio (95% confidence
intervals)to 2 d.p.
Oral steroids <7.5mg 0.754 0.910 0.829 90.072 on
89
89.440 on 88 0.407 2.13 (0.36–12.63)
Statin 0.112 0.530 0.211 90.072 on
89
90.028 on 88 0.833 1.12 (0.40–3.16)
Number of comorbidities 0.129 0.086 1.494 90.072 on
89
87.841 on 88 0.135 1.14 (0.96–1.35)
COPD 0.260 0.644 0.403 90.072 on
89
89.914 on 88 0.687 1.30 (0.37–4.58)
Any resp 0.642 0.578 1.110 90.072 on
89
88.888 on 88 0.267 1.90 (0.61–5.90)
Cerebrovascular disease -0.097 0.703 -0.138 90.072 on
89
90.053 on 88 0.89 0.91 (0.23–3.60)
Diabetes mellitus 0.789 0.763 1.034 90.072 on
89
89.082 on 88 0.301 2.20 (0.49–9.81)
Dementia 1.526 0.865 1.765 90.072 on
89
87.147 on 88 0.078 4.60 (0.84–25.06)
Cardiovascular disease 0.598 0.539 1.109 90.072 on
89
88.862 on 88 0.267 1.82 (0.63–5.23)
Active cancer 2.600 0.890 2.923 90.072 on
89
80.425 on 88 0.003** 13.46 (2.35–76.95)
Antibiotics pre admit 1.253 0.614 2.040 90.072 on
89
86.141 on 88 0.041 * 3.50 (1.05–11.66)
Current smoking -0.104 0.712 -0.145 90.072 on
89
90.052 on 88 0.884 0.90 (0.22–3.64)
Ex or current smoker -0.682 0.618 -1.104 90.072 on
89
88.753 on 88 0.269 0.51 (0.15–1.70)
Length of stay (days)(log) 0.925 0.346 2.678 90.072 on
89
81.901 on 88 0.007
**
2.52 (1.28–4.97)
Witnessed aspiration 2.653 1.189 2.231 90.072 on
89
84.104 on 88 0.026 * 14.20 (1.38–146.06)
Abbreviations: HAP = hospital acquired pneumonia, LRTI = lower respiratory tract infection, d.p. = decimal places, PQS = plaque quartile score,
IMD = Index of multiple deprivation score, HABAM = Hierarchical Assessment of Balance and Mobility, PPI = proton pump inhibitor, ACE-I = Angiotensin
converting enzyme inhibitor, Cef vs teic = Whether the patient received Cefuroxime or Teicoplanin perioperatively, COPD = Combined obstructive
pulmonary disease, Any resp = Any respiratory comorbidity
1: includes S. aureus, MRSA, P. aeruginosa, E. coli
doi:10.1371/journal.pone.0123622.t003
Table 4. Association between HAP and presence of opportunistic organisms by day sampled.
Day Estimate Standard error Z value Null deviance Residual
deviance
P value Odds ratio (95% confidence intervals)to 2 d.p.
1 0.758 0.470 1.612 154.55 on 199 152.14 on 198 0.107 2.13 (0.85–5.36)
3 0.460 0.614 0.749 107.42 on 176 106.90 on 175 0.454 1.58 (0.48–5.28)
5 1.479 0.476 3.105 139.61 on 173 130.63 on 172 0.002 ** 4.39 (1.73–11.16)
7 1.099 0.596 1.842 99.953 on 161 96.904 on 160 0.065. 3.00 (0.93–9.65)
14 1.900 0.522 3.644 117.70 on 137 104.95 on 136 <0.001 *** 6.69 (2.40–18.60)
doi:10.1371/journal.pone.0123622.t004
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had antibiotics before hospital admission (p = 0.041, OR 3.50, 95% CI 1.05–11.66), and worse
mobility score (p = 0.039, OR 0.95, 95% CI 0.91–1.00). We did not undertake multivariate re-
gression because of the small number of cases in this study.
We then created a correlation matrix to look for collinearity between the significant vari-
ables described above (Table 5). Significant collinearity was defined as an estimate greater than
0.2 (or less than-0.2), and was seen between worse mobility/increased frailty and being admit-
ted from an institution/hospital, between increased frailty and worse mobility, increased Charl-
son index and active cancer, and between active cancer and witnessed aspiration episodes.
Colonisation with opportunistic organisms was most strongly collinear with having active can-
cer and witnessed aspiration episodes.
Given that previous studies found respiratory tract infection or aspiration pneumonia was
associated with poor dentition, while we found no associations, we investigated whether colo-
nisation with any organism was associated with dental factors (S2 Table) using the dental
model (described above in Methods). Being colonised with E. coli was significantly commoner
in those without teeth or dentures, and increased S. aureus colonisation was seen in those with
higher admission plaque scores. In keeping with the notion of S. pneumoniae being protective
against HAP, colonisation with S. pneumoniae was associated with having more teeth and
being less frail. Smoking was a common risk factor for all organisms studied other thanH.
influenzae. Interestingly S. pneumoniae was also associated with being less deprived, whileH.
influenzae was associated with being more deprived.
Discussion
In this study, HAP was not associated with tooth number or prior heavy dental/denture plaque,
but was significantly associated with two or more samples positive with either S. aureus,
MRSA, E. coli or P. aeruginosa at any time point, and specifically at days 5 and 14 after
Table 5. Colinearity between covaiates which were significantly associated with HAP.
Admitted from
hospital/
institution
HABAM Charlson
Index
Abx pre
admission
Witnesed
aspiration
Active
cancer
>2 samples positive
with opportunistic
orgs.
Clinical
frailty score
Admitted from
hosp./inst.
1 Pearson Pearson Polyserial Polyserial Polyserial Pearson Pearson
HABAM -0.516 1 Pearson Polyserial Polyserial Polyserial Pearson Pearson
Charlson Index 0.144 -0.368 1 Polyserial Polyserial Polyserial Pearson Pearson
Abx pre
admission
0.040 -0.123 0.136 1 Polychoric Polychoric Polyserial Polyserial
Witnessed
aspiration
0.273 -0.321 0.440 -0.646 1 Polychoric Polyserial Polyserial
Active cancer -0.031 0.046 0.522 -0.099 0.617 1 Polyserial Polyserial
>2 samples
pos. opp. orgs.
-0.059 0.004 0.160 0.171 0.225 0.269 1 Pearson
Clinical frailty
score
0.481 -0.759 0.362 0.163 0.394 0.246 -0.018 1
Abbreviations: HABAM = Hierarchical Assessment of Balance and Mobility, ABX = antibiotics, orgs. = organisms. Variables which were co-linear
(correlation estimate >0.20) are highlighted in boldface. The higher the number, the stronger the correlation. Negative correlation estimates mean the
variable on the ‘y’ axis was associated with a lower score of the variable in the ‘x’ axis (e.g. higher Charlson index was associated with a lower or worse
HABAM/mobility score). Where covariates are binomial (e.g. Admitted from hospital/institution, a negative correlation estimate refers to that event NOT
having happened (e.g. higher HABAM/mobility score was associated with not having been admitted from hospital/institution, or in other words, having
been admitted from home.). Covariates in the ‘y’ axis have been abbreviated to make viewing the table easier.
doi:10.1371/journal.pone.0123622.t005
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admission. One previous study reported finding a significant association between aspiration
pneumonia and S. aureus in saliva [29], and these findings are similar to those from patients
with VAP [49, 50], but there are no other studies with which to compare these findings in non-
ventilated HAP, to our knowledge. Both studies of oropharyngeal colonization in VAP patients
noted that different outcomes were associated with colonization by two groups of organisms- a
S. pneumoniae/ H. influenzae group and an Enterobactericeae/ P. aeruginosa group [49, 50] (S.
aureus was placed in the first [50], and the second group [49]). HAP resulted in a mean of 30
excess days in hospital per patient and 50% of cases occurred in the first 25 days of admission.
In addition, patients with higher Charlson indices or active cancer were at increased risk of
HAP.
While this was a small study, it combined dental covariates with microbial data detected by
real-time PCR, using purpose-designed assays for clinically relevant organisms, and repeated
sampling to improve detection of colonization over time. While oropharyngeal colonization by
potentially pathogenic organisms has been previously described in older hospitalized persons
[12, 33, 34, 46, 51, 52], molecular methods have not been previously used. The study added use-
ful information regarding incidence of HAP in persons colonised and uncolonised by opportu-
nistic organisms, which may inform power calculations for future intervention trials. The
study added data concerning the timing of first colonization event, important information
about the significance of the presence of opportunistic organisms later in hospital admission,
baseline dental data from hospital patients and also data regarding excess length of stay. De-
spite the size, the study detected differences between incidence of HAP in exposed and unex-
posed participants of 31.2%, and the incidence of HAP in unexposed persons was 4.1%, which
was lower than that used in the power calculation. The organisms implicated in this study
might be piloted as endpoints to determine the effectiveness of oral hygiene interventions in
intervention trials.
Colonisation with opportunistic organisms only explained 20% of the variance, suggesting
other risk factors are of importance- i.e. that the presence of these organisms alone does not
necessarily lead to HAP. Other significant risk factors for HAP in this study suggest the hy-
pothesis that significant multimorbidity (increased Charlson index) and/or active cancer drive
both colonization with opportunistic organisms and also tendency to aspiration, possibly via
frailty. Patients who aspirate may have impaired swallow reflexes that decrease mechanical
clearance in the mouth, both increasing colonization with opportunistic organisms [53] and
the likelihood that these organisms will be delivered to the bronchial tree. Structural equation
modelling, which incorporates a temporal element, might clarify these interactions more realis-
tically, using conceptual models as described by Dickson et al. [54]. Interventions ought to ad-
dress as many risk factors as possible to prevent HAP, by promoting an aerodigestive tract
which minimizes delivery of organisms to the bronchial tree, impede bacterial overgrowth, and
optimize the habitat for core oral microbiota. Such interventions might include improving
swallow (ACE-inhibitors or oral hygiene), reducing bacterial bioburden (oral hygiene), avoid-
ing decreased conscious level (avoiding opiates, sedating drugs, general anaesthetics), use of
probiotics, optimising nutritional intake, promoting upright positioning and mobility, and
avoiding indwelling plastics which rapidly become colonized, such as nasogastric tubes, where
possible.
Future HAP studies should include a bedside swallow assessment in order to systematically
assess aspiration risk. Larger studies are needed to trial possible interventions and in order to
undertake multivariate modelling, perhaps aiming to recruit 100 cases of HAP. Oral colonisa-
tion with respiratory pathogens began within 72 hours of admission in the majority of cases,
implicating either events early in admission or even in the community, rather than the hospital
environment, as the source of opportunistic organisms. Thus interventions to manipulate the
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oral microbiota and subsequent risk of pneumonia might begin within this timeframe, and
pre-operatively where appropriate. In addition, given that potentially pathogenic organisms
were found on the tongue and the throat, oral hygiene interventions ought to be directed to,
but not necessarily limited to, the tongue and throat.
The results from this study are not directly generalizable to medical patients because study
patients experienced fracture, pain, anaesthesia and operation. However the organisms impli-
cated in this study are also seen more frequently with increasing severity of COPD [51], and S.
aureus has also previously been found to be a risk factor for aspiration pneumonia in medical
patients[12]. It is unfortunate that we were not able to satisfactorily develop and validate a PCR
assay to look for Klebsiella pneumoniae or other Enterobactericeae because several studies have
noted the increased prevalence of these organisms in frail, institutionalized patients, and in
those who are increasingly unwell [33, 34, 46, 52], and it seems possible that these organisms
might have represented an additional risk factor for HAP. It should be noted that some patients
received broad spectrum antibiotics, and other narrower spectrum antibiotics, but that these,
and the use of chlorhexidine for eradication of MRSA may have reduced detection of organ-
isms sought in the study.
Plaque scores were moderate for the group (mean scores of>2 are thought of as high). In
this small study, HAP was not associated with the presence of dental/denture plaque which
was consistent with results from a study of ventilated patients [16]. This may be a real finding,
or may be that the study was underpowered to detect a difference. Another explanation might
be that plaque needs to be colonized with particular organisms in order to promote HAP, as
described in a study of nosocomial infection in ventilated patients [16], and indeed increased
colonization with S. aureus was associated with higher plaque scores.
These findings need to be interpreted in light of the relatively small sample size, which
might underestimate the significance of smaller effects. The study was adequately powered
(80% power, 5% significance level) to distinguish between variables where the odds ratio was
just under 4, but insufficiently powered to determine smaller differences than this [32]. Despite
this, significant findings were obtained, and given that there is very little data in this area, the
results from this study will help to inform future studies. The sample was biased towards well
patients, which may have led to underestimation of both the exposures and the main outcome
variables.
Pneumonia is difficult to diagnose reliably, and incidence varies with criteria used [55]. Best
diagnostic practice should include bronchoalveloar lavage [55], which was not clinically appro-
priate in this group of patients. Therefore it is likely that the incidence of HAP found in this
study is overestimated. Well-conducted randomised-controlled trials of interventions with
pragmatic clinical endpoints are probably the next step given that this group of frail patients is
at high risk of HAP.
This study only sampled patients for the first 14 days after admission, and oral bacterial
communities may have changed after this time, or between samples, affecting the risk of HAP
at a later point in the patient’s admission. The combination of tongue/throat samples was the
minimally inclusive combination achievable in those with cognitive impairment; oral rinses,
the gold standard were not possible in this group [24]. It should be noted that the colonization
index data were zero inflated and there is a possibility of over-predicting the significance of pa-
tient factors where colonization index was larger than zero. Nasopharyngeal sampling was not
undertaken in this study, partly because there was more previous research concerning target
organisms in the oropharynx in this patient group, and partly because of the additional re-
sources which would have been needed. However we acknowledge that this approach may
have decreased the yield of S. pneumoniae and H. influenzae in particular [56]. S. pneumoniae
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occurred more commonly in the fitter patients in this study, possibly due to greater interaction
with other persons in the community or family members.
Future studies investigating HAP in non-ventilated hospital patients ought to unite oral
microbiological parameters using next-generation sequencing and functional metagenomics
techniques with swallowing assessment, and possibly “environmental”measures of the aerodi-
gestive tract, to better understand how these risk factors interact with each other and patient
multimorbidity. Intervention trials to prevent HAP need to determine the optimal, most cost-
effective methods to prevent HAP, which might include oral hygiene, swallow assessment and
management and possibly medication management. In addition, methods of implementing
and delivering better oral hygiene at ward-level in a resource-scarce health system need to be
investigated, in order to minimise use of antibiotics and length of hospital stay associated with
HAP.
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